Capricor Therapeutics Inc (CAPR) is a publicly traded Healthcare sector company. As of August 15, 2026, CAPR trades at $6.51 with a market cap of $386.42M and a P/E ratio of -5.66. CAPR moved +57.96% today. Year to date, CAPR is -76.96%; over the trailing twelve months it is -19.88%. Its 52-week range spans $2.96 to $40.37. Analyst consensus is neutral with an average price target of $4.38. Rallies surfaces CAPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Capricor Therapeutics Inc (CAPR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CAPR moved +57.96% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $6.51 |
| Market Cap | $386.42M |
| P/E Ratio | -5.66 |
| EPS | $-1.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.37 |
| 52-Week Low | $2.96 |
| Volume | 64.80M |
| Avg Volume | 0 |
| Revenue (TTM) | $22.27M |
| Net Income | $-40.47M |
| Gross Margin | 0.00% |
10 analysts cover CAPR: 0 strong buy, 0 buy, 10 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.38.